Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y12 receptor antagonist-treated rats provides long-term reduction in myocardial infarct size and preservation of ventricular function

Overview of attention for article published in Basic Research in Cardiology, July 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 133 Dimensions

Readers on

mendeley: 65 Mendeley

Summary Wikipedia Dimensions citations

So far, Altmetric has seen 1 Wikipedia article.

Belnacasan

Cited by user Meodipt on 19 Oct 2018

Belnacasan (VX-765) is a drug developed by Vertex Pharmaceuticals which acts as a potent and selective inhibitor of the enzyme Caspase 1.